CDEK by Data4ThePeople

Sign in Sign up

← All organizations

T3D Therapeutics, Inc.

For profitWebsite ↗

Also known as: T3D Therapeutics, Inc. | T3DTherapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Oct 26, 2026

Timeline

2010s

Jun 1, 2013
T3D Therapeutics, Inc.— Founded

Drugs by trial phase (1 distinct, 3 trials)

Phase 3 (1 own, 0 via acquisition)

t3d-959

Indications

Studied for

Alzheimer Disease

Recent trials (7)

NCT06964230Sponsor investigatorPhase 2/Phase 3Oct 26, 2026
NCT06964230OfficialPhase 2/Phase 3Oct 26, 2026
NCT06964230Lead sponsorPhase 2/Phase 3Oct 26, 2026
NCT04251182Lead sponsorPhase 2Feb 5, 2020
NCT04251182Study directorPhase 2Feb 5, 2020
NCT02560753Study chairPhase 1/Phase 2Jul 1, 2015
NCT02560753Lead sponsorPhase 1/Phase 2Jul 1, 2015

Details

Founded: Durham, NC, US Jun 1, 2013
Last known activity: Oct 26, 2026